PLK1 and neoplasm: Therefore, the downregulation of this RI might be a key factor leading to the aberrant expression of the dominant PLK1 isoform (PLK1‐201) by splicing PLK1‐N1 to PLK1‐201 (Figure 6H), thereby affecting tumor progression.